Notice2021-24320
Advisory Committee on Immunization Practices (ACIP); Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 8, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC), announces the following meeting of the Advisory Committee on Immunization Practices (ACIP). This meeting is open to the public. Time will be available for public comment. The meeting will be webcast live via the World Wide Web; for more information on ACIP please visit the ACIP website: http:/ /www.cdc.gov/vaccines/acip/index.html.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 213 (Monday, November 8, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 213 (Monday, November 8, 2021)]
[Notices]
[Pages 61766-61767]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-24320]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2021-0098]
Advisory Committee on Immunization Practices (ACIP); Amended
Notice of Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), announces the
following meeting of the Advisory Committee on Immunization Practices
(ACIP). This meeting is open to the public. Time will be available for
public comment. The meeting will be webcast live via the World Wide
Web; for more information on ACIP please visit the ACIP website: <a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>.
[[Page 61767]]
DATES: The meeting will be held on October 20-21, 2021, from 10:00 a.m.
to 5:00 p.m., EDT (times subject to change). The docket is currently
open to receive written comments. Written comments must be received on
or before October 21, 2021.
SUPPLEMENTARY INFORMATION: Notice is hereby given of a change in the
meeting of the Advisory Committee on Immunization Practices (ACIP);
October 20, 2021, 10:00 a.m.-5:00 p.m., EDT, and October 21, 2021,
10:00 a.m.-5:00 p.m., EDT (times subject to change), in the original
FRN.
The virtual meeting was published in the Federal Register on
Wednesday, September 22, 2021, Volume 86, Number 181, pages 52683-
52684.
The virtual meeting is being amended to change the date the docket
was opened to receive written public comments, and updates to the
Matters To Be Considered and Written Public Comment sections of the
notice and should read as follows:
DATES: The meeting will be held on October 20-21, 2021, from 10:00 a.m.
to 5:00 p.m., EDT (times subject to change). The public may submit
written comments from October 7, 2021 through October 21, 2021.
Matters To Be Considered: The agenda will include discussions on
herpes zoster vaccines, influenza vaccines, pneumococcal vaccine, and
COVID-19 vaccines. Recommendation votes on herpes zoster vaccine,
pneumococcal vaccine, and COVID-19 vaccines are scheduled. No Vaccines
for Children (VFC) votes are scheduled. Agenda items are subject to
change as priorities dictate. For more information on ACIP please visit
the ACIP website: <a href="http://www.cdc.gov/vaccines/acip/index.html">http://www.cdc.gov/vaccines/acip/index.html</a>.
Written Public Comment: The docket will be opened to receive
written comments on October 7, 2021. Written comments must be received
on or before October 21, 2021.
The virtual meeting is open to the public.
FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, ACIP Committee
Management Specialist, Centers for Disease Control and Prevention,
National Center for Immunization and Respiratory Diseases, 1600 Clifton
Road NE, MS-H24-8, Atlanta, GA 30329-4027; Telephone: 404-639-8367;
Email: <a href="/cdn-cgi/l/email-protection#5011131900103334337e373f26"><span class="__cf_email__" data-cfemail="9bdad8d2cbdbf8fff8b5fcf4ed">[email protected]</span></a>.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-24320 Filed 11-5-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on November 8, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.